ASTH

SEC source: 0001104659-19-069171 · tm1924375-1_4.xml · nonDerivative · entry 1

Young Albert WaiChow · CIK 0001725420 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 918,331

F1 · kind: Restricted shares of Apollo Medical Holdings, Inc.'s (the "Company") Common Stock granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third on March 31, 2020, one-third on March 31, 2021, and the final one-third on March 31, 2022.

SEC source: 0001104659-19-067796 · tm1924007-1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,890,778

F1 · price: This transaction was executed in multiple trades at prices ranging from $17.82 to $18.00. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-067168 · tm1923895d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,880,778

F1 · price: This transaction was executed in multiple trades at prices ranging from $16.90 to $17.67. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-075849 · tm1927354d4_4.xml · derivative · entry 1

Fawcett Mark · CIK 0001664134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,548

Underlying: Common Stock · 2,048 shares

Expires 2024-11-25

F1 · derivative.exercise_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-19-075846 · tm1927354d1_4.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,548

Underlying: Common Stock · 2,048 shares

Expires 2024-11-25

F1 · derivative.exercise_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-19-075848 · tm1927354d3_4.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,900

Underlying: Common Stock · 900 shares

Expires 2024-11-25

F1 · derivative.exercise_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-19-075847 · tm1927354d2_4.xml · derivative · entry 1

Kitayama Mitchell W · CIK 0001333154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,548

Underlying: Common Stock · 2,048 shares

Expires 2024-11-25

F1 · derivative.exercise_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

F1 · derivative.expiration_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020.

SEC source: 0001104659-19-066763 · tm1923781d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,847,778

F1 · price: This transaction was executed in multiple trades at prices ranging from $17.40 to $18.20. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-066340 · tm1923683d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,822,778

SEC source: 0001104659-19-065964 · tm1923576d1_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,820,878

F1 · price: This transaction was executed in multiple trades at prices ranging from $16.99 to $17.50. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001104659-19-065783 · tm1923454d2_4.xml · nonDerivative · entry 1

ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp · CIK 0001725602 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,808,778

SEC source: 0001104659-19-064844 · tm1923122-1_4.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · President and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by The Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,743,623

F1 · price: This transaction was executed in multiple trades at prices ranging from $14.70 to $14.92. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Excludes the Reporting Person's indirect ownership of common stock of Apollo Medical Holdings, Inc. as a shareholder of Allied Physicians of California, A Professional Medical Corporation.

F3 · ownership.nature: These shares are owned directly by The Thomas and Jeanette Lam 2002 Family Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001104659-19-065155 · tm1923130-1_4.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007

Disclosed balance after: 1,737,561

F1 · price: This transaction was executed in multiple trades at prices ranging from $14.54 to $14.73. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Excludes the Reporting Person's indirect ownership of common stock of Apollo Medical Holdings, Inc. as a shareholder of Allied Physicians of California, A Professional Medical Corporation.

F3 · ownership.nature: These 10,000 shares are owned directly by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these 10,000 shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these 10,000 shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001104659-19-065771 · tm1923454d1_4.xml · derivative · entry 1

BATES ERNEST A · CIK 0000946042 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,500

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

SEC source: 0001104659-19-065779 · tm1923454d8_4.xml · derivative · entry 1

Kitayama Mitchell W · CIK 0001333154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,500

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

SEC source: 0001104659-19-065782 · tm1923454d9_form4.xml · derivative · entry 1

Schmidt David · CIK 0001594029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,500

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

SEC source: 0001104659-19-065778 · tm1923454d7_4.xml · derivative · entry 1

Eng Michael F. · CIK 0001725261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,500

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

SEC source: 0001104659-19-065777 · tm1923454d6_4.xml · derivative · entry 1

Fawcett Mark · CIK 0001664134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,500

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

SEC source: 0001104659-19-065776 · tm1923454d5_4.xml · derivative · entry 1

Marsh Linda · CIK 0001765204 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,500

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for her service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for her service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

SEC source: 0001104659-19-065773 · tm1923454d3_4.xml · derivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

SEC source: 0001104659-19-065775 · tm1923454d4_4.xml · derivative · entry 1

Yu Li · CIK 0001387928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,500

Underlying: Common Stock · 11,000 shares

Expires 2024-10-11

F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020.

SEC source: 0001104659-19-057423 · tm1921338d1_4.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman and Co-CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007

Disclosed balance after: 1,727,561

F1 · kind: These 5,000 shares were acquired inadvertently without the knowledge of the Reporting Person. The Reporting Person placed an order with a broker for the purchase of 5,000 shares at $15.55 on August 22, 2019, which could not be filled at that time given the market price on that date. The Reporting Person believed that the order was cancelled. However, the broker treated the order as remaining open and the above purchase was executed by the broker on October 8, 2019 without the Reporting Person's knowledge.

F2 · balance_after: Excludes the Reporting Person's indirect ownership of common stock of Apollo Medical Holdings, Inc. as a shareholder of Allied Physicians of California, A Professional Medical Corporation.

F3 · ownership.nature: These 5,000 shares are owned directly by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007. The Reporting Person disclaims beneficial ownership of these 5,000 shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these 5,000 shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001144204-19-046901 · tv530494_4.xml · derivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,189

Underlying: Common Stock · 39,189 shares

Expires 2024-09-30

F2 · derivative.exercise_price: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on September 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date of grant (i.e., September 30, 2019).

F2 · kind: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on September 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date of grant (i.e., September 30, 2019).

F2 · derivative.exercise_date: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on September 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date of grant (i.e., September 30, 2019).

SEC source: 0001144204-19-046901 · tv530494_4.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,883

F1 · kind: Restricted shares of Apollo Medical Holdings, Inc.'s (the "Company") Common Stock granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022).

SEC source: 0001144204-19-046903 · tv530495_4.xml · derivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,189

Underlying: Common Stock · 39,189 shares

Expires 2024-09-30

F2 · derivative.exercise_price: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on September 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date of grant (i.e., September 30, 2019).

F2 · kind: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on September 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date of grant (i.e., September 30, 2019).

F2 · derivative.exercise_date: Stock option to purchase the Company's Common Stock granted under the Company's 2015 Equity Incentive Plan, which stock option will vest and become exercisable one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022), subject to expiration on the date that is five years from the date of grant (i.e., on September 30, 2024). The exercise price for each share subject to the stock option granted shall be set at the closing price of the Company's Common Stock on the date of grant (i.e., September 30, 2019).

SEC source: 0001144204-19-046903 · tv530495_4.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · Co-Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,883

F1 · kind: Restricted shares of Apollo Medical Holdings, Inc.'s (the "Company") Common Stock granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third after year one (on September 30, 2020), one-third after year two (on September 30, 2021), and the final one-third after year three (on September 30, 2022).

SEC source: 0001144204-19-044820 · tv529553_4.xml · nonDerivative · entry 3

Vazquez Adrian · CIK 0001438326 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 520,941

SEC source: 0001144204-19-044784 · tv529550_4.xml · nonDerivative · entry 1

Eng Michael F. · CIK 0001725261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

SEC source: 0001144204-19-044820 · tv529553_4.xml · nonDerivative · entry 2

Vazquez Adrian · CIK 0001438326 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 548,291

SEC source: 0001553350-19-000945 · young4.xml · nonDerivative · entry 1

Young Albert WaiChow · CIK 0001725420 · Co-Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Allied Physicians of California, A Professional Medical Corporation

Disclosed balance after: 16,750,575

F1 · kind: On September 11, 2019, Apollo Holdings, Medical Inc. ("AMEH"), AP-AMH Medical Corporation ("AP-AMH"), Allied Physicians of California, a Professional Medical Corporation ("APC") and Network Medical Management, Inc. concurrently closed a series of inter-connected transactions, as more fully described in the Form 8-K filed by AMEH with the Securities and Exchange Commission on September 12, 2019. The closing included AMEH issuing to APC a total of 15,015,015 shares of its authorized and unissued common stock for aggregate purchase consideration of $300,000,000, the per share price of $19.98 having been determined at the time of execution of the Stock Purchase Agreement on May 10, 2019. The transaction was exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and Rule 506(b) of Regulation D promulgated thereunder, applicable to transactions by an issuer not involving any public offering.

F2 · ownership.nature: These shares are owned directly by APC of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

SEC source: 0001553350-19-000944 · sim4.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Allied Physicians of California, A Professional Medical Corporation

Disclosed balance after: 16,790,575

F1 · kind: On September 11, 2019, Apollo Holdings, Medical Inc. ("AMEH"), AP-AMH Medical Corporation ("AP-AMH"), Allied Physicians of California, a Professional Medical Corporation ("APC") and Network Medical Management, Inc. concurrently closed a series of inter-connected transactions, as more fully described in the Form 8-K filed by AMEH with the Securities and Exchange Commission on September 12, 2019. The closing included AMEH issuing to APC a total of 15,015,015 shares of its authorized and unissued common stock for aggregate purchase consideration of $300,000,000, the per share price of $19.98 having been determined at the time of execution of the Stock Purchase Agreement on May 10, 2019. The transaction was exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and Rule 506(b) of Regulation D promulgated thereunder, applicable to transactions by an issuer not involving any public offering.

F2 · ownership.nature: These shares are owned directly by APC of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

SEC source: 0001553350-19-000943 · lam4.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Allied Physicians of California, A Professional Medical Corporation

Disclosed balance after: 16,790,575

F1 · kind: On September 11, 2019, Apollo Holdings, Medical Inc. ("AMEH"), AP-AMH Medical Corporation ("AP-AMH"), Allied Physicians of California, a Professional Medical Corporation ("APC") and Network Medical Management, Inc. concurrently closed a series of inter-connected transactions, as more fully described in the Form 8-K filed by AMEH with the Securities and Exchange Commission on September 12, 2019. The closing included AMEH issuing to APC a total of 15,015,015 shares of its authorized and unissued common stock for aggregate purchase consideration of $300,000,000, the per share price of $19.98 having been determined at the time of execution of the Stock Purchase Agreement on May 10, 2019. The transaction was exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and Rule 506(b) of Regulation D promulgated thereunder, applicable to transactions by an issuer not involving any public offering.

F2 · ownership.nature: These shares are owned directly by APC of which Reporting Person is a director, officer and shareholder. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

SEC source: 0001144204-19-044820 · tv529553_4.xml · nonDerivative · entry 1

Vazquez Adrian · CIK 0001438326 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 562,037

SEC source: 0001553350-19-000873 · eng4.xml · nonDerivative · entry 1

Eng Michael F. · CIK 0001725261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

SEC source: 0001553350-19-000868 · sim4.xml · nonDerivative · entry 5

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Kenneth T. Sim Pension Plan Trust dated 12/18/2007

Disclosed balance after: 1,663,678

F1 · ownership.nature: These shares are owned directly by the Kenneth T. Sim Pension Plan Trust dated 12/18/2007. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001553350-19-000868 · sim4.xml · nonDerivative · entry 4

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Kenneth T. Sim Pension Plan Trust dated 12/18/2007

Disclosed balance after: 1,663,115

F1 · ownership.nature: These shares are owned directly by the Kenneth T. Sim Pension Plan Trust dated 12/18/2007. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001553350-19-000868 · sim4.xml · nonDerivative · entry 3

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Kenneth T. Sim Pension Plan Trust dated 12/18/2007

Disclosed balance after: 1,662,678

F1 · ownership.nature: These shares are owned directly by the Kenneth T. Sim Pension Plan Trust dated 12/18/2007. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001553350-19-000868 · sim4.xml · nonDerivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Kenneth T. Sim Pension Plan Trust dated 12/18/2007

Disclosed balance after: 1,661,178

F1 · ownership.nature: These shares are owned directly by the Kenneth T. Sim Pension Plan Trust dated 12/18/2007. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001553350-19-000874 · lam4.xml · nonDerivative · entry 3

Lam Thomas S. · CIK 0001664499 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by The Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,674,740

F4 · price: This transaction was executed in multiple trades at prices ranging from $16.09 to $16.21. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These shares are owned directly by The Thomas and Jeanette Lam 2002 Family Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001553350-19-000874 · lam4.xml · nonDerivative · entry 2

Lam Thomas S. · CIK 0001664499 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by The Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,668,740

F3 · price: This transaction was executed in multiple trades at prices ranging from $15.55 to $15.60. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These shares are owned directly by The Thomas and Jeanette Lam 2002 Family Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001553350-19-000875 · young4.xml · nonDerivative · entry 1

Young Albert WaiChow · CIK 0001725420 · Co-Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 916,446

SEC source: 0001553350-19-000868 · sim4.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Kenneth T. Sim Pension Plan Trust dated 12/18/2007

Disclosed balance after: 1,659,678

F1 · ownership.nature: These shares are owned directly by the Kenneth T. Sim Pension Plan Trust dated 12/18/2007. Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001553350-19-000874 · lam4.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by The Thomas and Jeanette Lam 2002 Family Trust

Disclosed balance after: 1,664,740

F1 · price: This transaction was executed in multiple trades at prices ranging from $16.63 to $16.92. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These shares are owned directly by The Thomas and Jeanette Lam 2002 Family Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or for any other purpose.

SEC source: 0001553350-19-000653 · ownership.xml · nonDerivative · entry 1

Chiang John · CIK 0001765302 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100

SEC source: 0001553350-19-000637 · sim4.xml · nonDerivative · entry 2

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,657,678

SEC source: 0001553350-19-000640 · ownership.xml · nonDerivative · entry 1

Chin Eric · CIK 0001751197 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,639

SEC source: 0001553350-19-000639 · ownership.xml · nonDerivative · entry 1

Fawcett Mark · CIK 0001664134 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

SEC source: 0001553350-19-000638 · lam4.xml · nonDerivative · entry 1

Lam Thomas S. · CIK 0001664499 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,657,540

SEC source: 0001553350-19-000637 · sim4.xml · nonDerivative · entry 1

Sim Kenneth T. · CIK 0001725499 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,656,378

SEC source: 0001567619-19-012853 · doc1.xml · nonDerivative · entry 2

Vazquez Adrian · CIK 0001438326 · Co-Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 605,741